Aclipse Therapeutics
-
Radnor Firm Aclipse Therapeutics Receives Australian Grant to Develop ALS Therapy
A Radnor biopharmaceutical company has been awarded $720,000 to fund an experimental therapy being developed there for amyotrophic lateral sclerosis (ALS), writes John George for…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
